SIGA Technologies Logo
SIGA Announces Public Health Agency of Canada Intent to Purchase Up To 33,300 Courses of Oral TPOXX®
October 08, 2020 07:30 ET | SIGA Technologies Inc.
Public Health Agency of Canada Contract would be Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXXDelivery of 18,500 Courses by March 31, 2023; Delivery of Additional...
SIGA Technologies Logo
SIGA to Participate at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020
September 10, 2020 08:30 ET | SIGA Technologies Inc.
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies Logo
Dr. Dennis Hruby Wins 2021 ASM Award for Applied and Biotechnological Research
August 31, 2020 07:30 ET | SIGA Technologies Inc.
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies Logo
SIGA Technologies, Inc. Reports Financial Results for Three and Six Months Ended June 30, 2020
August 06, 2020 16:05 ET | SIGA Technologies Inc.
- Second Quarter includes Deliveries to SNS and First International Delivery - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- SIGA...
SIGA Technologies Logo
SIGA Technologies to Host Business Update Call on August 6, 2020 Following Release of Second Quarter Financial Results
July 30, 2020 16:01 ET | SIGA Technologies Inc.
NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Technologies Logo
SIGA Announces Marketing Authorization Filing for oral tecovirimat with the European Medicines Agency for Multiple Indications
July 30, 2020 07:30 ET | SIGA Technologies Inc.
- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications - NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA Technologies Logo
SIGA Announces Deliveries of Oral TPOXX® to HHS Valued at Approximately $32 Million
June 25, 2020 16:05 ET | SIGA Technologies Inc.
First Deliveries of Contract Option Exercises Announced in April 2020 NEW YORK, June 25, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical...
SIGA Technologies Logo
SIGA Changes its 2020 Annual Meeting of Stockholders to Virtual Format
June 01, 2020 17:00 ET | SIGA Technologies Inc.
NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA Technologies Logo
SIGA Technologies Announces First International Delivery of Oral TPOXX®
June 01, 2020 09:01 ET | SIGA Technologies Inc.
- 2,500 Courses Delivered to the Canadian Department of National Defence - NEW YORK, June 01, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage...
SIGA Technologies Logo
SIGA Technologies, Inc. Reports Financial Results for the First Quarter of 2020
May 06, 2020 16:05 ET | SIGA Technologies Inc.
- Company Recently Announced Exercise of Contract Options Totaling $101.3 million - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- SIGA...